CYRX News and Press, CryoPort Inc. From 04/18/22

Cryoport Acquires Cell&Co BioServices Cryoport Acquires Cell&Co BioServices PR Newswire Acquisition of Cell&Co BioServices, Clermont-Ferrand , France, accelerates Company's EMEA expansion plans and development of its Global Supply Chain Network...

Being a logistics service provider for the booming cell/gene therapy sector, Cryoport is enjoying the robust industry tailwind and thereby positioning itself to be an investment bonanza. Various acquisitions like MVE Biological Solutions and CryoPDP are delivering leaping top-line gro...

Cryoport has a history of success until recently, posting gains in revenue on its income statement for each of the last four years. The company does come with risks; a recent fire in one of its facilities and a consistent negative net income rating are the two most prevalent. The ...

Cryoport (NASDAQ:CYRX) on Wednesday said its New Prague facility returned to full production. A fire occurred in a portion of the CYRX unit MVE Biological Solutions manufacturing facility in New Prague, Minnesota on Jan. 25, causing production to be temporarily curtailed. Production resumed a...

Cryoport's MVE Biological Solutions' New Prague Manufacturing Plant Returns to Full Production PR Newswire Company provides further update on financial impact of New Prague, MN fire NASHVILLE, Tenn. , March 30, 2022 /PRNewswire/ -- Cryoport, Inc. (Nas...

Cryoport's (NASDAQ:CYRX) board has unanimously authorized a repurchase program, under which Cryoport may repurchase up to $100M of its outstanding common stock and/or convertible senior notes.  The repurchase program will expire on December 31, 2025. The company does not expect to incur ...

Cryoport Authorizes $100 Million Repurchase Program PR Newswire Management Presenting at Upcoming Investor Conferences NASHVILLE, Tenn. , March 11, 2022 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in t...

Cryoport, Inc. (CYRX) Q4 2021 Earnings Conference Call February 24, 2022, 5:00 PM ET Company Participants Todd Fromer - President, KCSA Strategic Communications Jerrell Shelton - Chief Executive Officer Robert Stefanovich - Chief Financial Officer Dr. Mark Sawicki - Chief Scientific Officer T...

CryoPort press release (NASDAQ:CYRX): Q4 GAAP EPS of -$5.46 may not be comparable to consensus of -$0.13. Revenue of $56.4M (+16.6% Y/Y) misses by $1.33M. Gross margin was 41.0% for the fourth quarter of 2021 compared to 41.1% for the fourth quarter of 2020. Adjusted EBITDA for the fourt...

Cryoport Reports Fourth Quarter and Full Year 2021 Results - 2021 annual revenue grew to $222.6 million, representing 183% year-over-year growth - Cryoport Systems and CRYOGENE revenue grew 34% year-over-year for the fourth quarter - Enters 2022 with $629 million in cash...